Specialist warns of ‘hidden’ issue of addiction as evidence gap remains ‘huge’ by Steve Jones February 20, 2024February 20, 2024 Medicinal cannabis will remain the domain of “aberrant” doctors until the “huge” evidence gap is filled, […]
Administrators slim down Epsilon board as investigations continue by Steve Jones February 15, 2024February 15, 2024
Growers’ worst nightmare: Hop Latent Viroid detected in Australia by Steve Jones February 15, 2024February 15, 2024
Cann I Help launches rapid access program to fast track medicine to patients in need by Steve Jones February 14, 2024February 14, 2024
Australia ‘watching closely’ as Israel launches Canada anti-dumping probe by Steve Jones February 8, 2024February 8, 2024
Hemp taskforce launches in NSW with aim to remove barriers and map out growth plan by Steve Jones February 8, 2024February 8, 2024
Emyria S3 CBD trial ‘on hold’ as firm stresses need to focus on revenue by Steve Jones February 7, 2024February 7, 2024
Clarity over German legal scheme paves way for AusCann-Eurocann deal by Steve Jones February 7, 2024February 7, 2024
Cannabis seeing ‘explosive growth’ but data reveals sales dogfight beyond the market leaders by Steve Jones February 1, 2024February 1, 2024
Cann Group delivers ‘modest’ growth as imports continue to frustrate by Steve Jones February 1, 2024February 1, 2024
